Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (881-890 of 1,119) with videos related to

Pageof 112
Sort By:
American Heart Journal|August 25, 2009
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in CanadaBasem Elbarouni, Shaun G Goodman, Raymond T Yan, et al.
Annals of Neurology|July 31, 2015
Sleep deficits but no metabolic deficits in premanifest Huntington's diseaseAlpar S Lazar, Francesca Panin, Anna O G Goodman, et al.
Diabetes Care|February 6, 2025
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized TrialGregory G Schwartz, Michael Szarek, J Wouter Jukema, et al.
Cardiology|January 30, 2024
Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective IIIMeshal Alanezi, Andrew T Yan, Mary K Tan, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 10, 2021
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trialE Hope Weissler, Robert M Clare, Yuliya Lokhnygina, et al.
Clinical Cardiology|November 13, 2019
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registryStuart J Pocock, David Brieger, John Gregson, et al.
Pageof 112

Showing results (881-890 of 1,119) with videos related to

Sort By:
Pageof 112
American Heart Journal|August 25, 2009
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in CanadaBasem Elbarouni, Shaun G Goodman, Raymond T Yan, et al.
Annals of Neurology|July 31, 2015
Sleep deficits but no metabolic deficits in premanifest Huntington's diseaseAlpar S Lazar, Francesca Panin, Anna O G Goodman, et al.
Diabetes Care|February 6, 2025
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized TrialGregory G Schwartz, Michael Szarek, J Wouter Jukema, et al.
Cardiology|January 30, 2024
Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective IIIMeshal Alanezi, Andrew T Yan, Mary K Tan, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
The American Journal of Cardiology|June 27, 2000
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)A Barbagelata, R M Califf, E B Sgarbossa, et al.
Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 10, 2021
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trialE Hope Weissler, Robert M Clare, Yuliya Lokhnygina, et al.
Clinical Cardiology|November 13, 2019
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registryStuart J Pocock, David Brieger, John Gregson, et al.
Pageof 112